CONy 2020 Headache Program
Section Heads:
*This program is subject to change
| Friday, March 27, 2020 | |
| 08:30-10:10 | SECTION TITLE |
| 08:30-09:20 | Mushrooms are a good treatment for chronic cluster headache. |
| Capsule: Psilocybin, lysergic acid diethylamide, and related psychedelic trIptamines were reportedly effective for both preventive and acute treatment of cluster headache, but is there scientific evidence to recommend it to our patients? | |
| 08:30-08:40 | Host: Dimos Mitsikostas, Greece |
| 08:40-08:55 | Yes: Brian E. McGeeney, USA |
| 08:55-09:10 | No: Randall Weeks, USA |
| 09:10-09:20 | Discussion and rebuttals |
| 09:20-10:10 | Acupuncture is at least as effective as migraine prophylactic drugs, but with fewer unwanted side effects. |
| Capsule: In recent years the evidence base for acupuncture as a prophylactic treatment for headache has grown considerably due to the publication of several large trials of high quality, but the results are still challenging and not easy to interpret. | |
| 09:20-09:30 | Host: Jose Miguel Lainez, Spain |
| 09:30-09:45 | Yes: Min Kyung Chu, South Korea |
| 09:45-10:00 | No: |
| 10:00-10:10 | Discussion and rebuttals |
| 10:10-10:25 | Coffee Break |
| 10:25-12:05 | SECTION TITLE |
| 10:25-11:10 | Head injury can precipitate the onset of migraine. |
| Capsule: Post-traumatic headache may be nonspecific in character and may have a symptom pattern indistinguishable from other non-traumatic headache syndromes such as migraine with or without aura. | |
| 10:25-10:35 | Host: Manjit Matharu, UK |
| 10:35-10:50 | Yes: Oved Daniel, Israel |
| 10:50-11:05 | No: Mark Braschinsky, Estonia |
| 11:05-11:10 | Discussion and rebuttals |
| 11:10-12:05 | Estrogen containing contraceptives are safe in women with migraine with aura. |
| Capsule: Migraine with aura has been associated with increased risk of ischemic and hemorrhagic stroke. Prior studies have shown a further increase in risk in women using combined hormonal contraceptives (CHCs). This has led to guidelines recommending against use of CHCs in this population. Recent data shows a lack of good quality studies assessing risk of stroke associated with low dose estrogen use in women with migraine. | |
| 11:10-11:20 | Host: Pooja Dassan, UK |
| 11:20-11:35 | Yes: Anne MacGregor, UK |
| 11:35-11:50 | No: Chris Gottschalk, USA |
| 11:50-11:55 | Discussion and rebuttals |
| 11:55-12:15 | How are the CGRP monoclonal antibodies being used today? Chris Gottschalk, USA |
| 12:15-13:15 | Industry Supported Symposium |
| 13:15-14:15 | Lunch Break |
| 13:15-14:15 | Meet the Expert |
| 14:15-15:45 | SECTION TITLE |
| 14:15-14:55 | Peripheral trigeminal structures are the primary interaction site for CGRP antagonism in migraine prevention |
| Capsule: CGRP plays a crucial role in migraine pathophysiology. Monoclonal antibodies to CGRP or its receptor will replace tradition preventive therapies form migraine. | |
| 14:15-14:25 | Host: Fayyaz Ahmed, UK |
| 14:25-14:35 | Yes: Lars Edvinsson, Sweden |
| 14:35-14:45 | No: Dimos Mitsikostas, Greece |
| 14:45-14:55 | Discussion and rebuttals |
| 14:55-15:45 | Vestibular migraine – does it exist? |
| Capsule: Vestibular migraine is a term used to describe episodic vertigo in migraine patients, but is it a distinct diagnosis, or simply a sensory manifestation of migraine? | |
| 14:55-15:05 | Host: Min Kyung Chu, South Korea |
| 15:05-15:20 | Yes: Christian Lampl, Austria |
| 15:20-15:35 | No: Jack Schim, USA |
| 15:35-15:45 | Discussion and rebuttals |
| 15:45-16:00 | Coffee Break |
| 16:00-19:00 | SECTION TITLE |
| 16:00-16:50 | Correcting the derangement in sleep architecture is sufficient to treat cluster and migraine headache without medication. |
| Capsule: Migraineurs and cluster headache patients who do not sleep well develop more frequent and severe headaches. Would optimal sleep therapies ever be good enough to take the place of medication for the treatment of these headaches, or is sleep impairment just an epiphenomenon? | |
| 16:00-16:10 | Host: Jack Schim, USA |
| 16:10-16:25 | Yes: Bojana Zvan, Slovenia |
| 16:25-16:40 | No: Oved Daniel, Israel |
| 16:40-16:50 | Discussion and rebuttals |
| 16:50-17:40 | Devices will replace medications for the treatment of headache. |
| Capsule: Medical devices are a rapidly growing field in the headache disorders provides an alternative therapeutic option particularly for Migraine and Cluster Headache. | |
| 16:50-17:00 | Host: Anna Anrdreou, UK |
| 17:00-17:15 | Yes: Jose Miguel Lainez, Spain |
| 17:15-17:30 | No: Giorgio Lambru, UK |
| 17:30-17:40 | Discussion and rebuttals |
| 17:40-18:30 | The safety and efficacy of CGRP mAbs are known enough to recommend them for long-term use. |
| 17:40-17:50 | Host: Giorgio Lambru, UK |
| 17:50-18:05 | Yes: Lars Edvinsson, Sweden |
| 18:05-18:20 | No: Fayyaz Ahmed, UK |
| 18:20-18:30 | Discussion and rebuttals |
| 18:30-19:00 | The changing face of medication-overuse headache Alan Rapoport, USA |